EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Use of Organoclays as Excipient for Metformin Delivery: Experimental and Computational Study

Sondes Omrani, Safa Gamoudi, César Viseras iD, Younes Moussaoui, C Ignacio Sainz-Díaz iD

Molecules · 2024

DOI: 10.3390/molecules29194612 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Sondes Omrani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for the Application of Materials to the Environment, Water and Energy (LR21ES15), Faculty of Sciences of Gafsa, University of Gafsa, Gafsa…. Hauptthemen laut MEDLINE: Metformin, Clay, Drug Carriers, Excipients. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades, Consejería de Economía, Conocimiento, Empresas y Universidad, Andalusian Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This work combines experimental and computational modeling studies for the preparation of a composite of metformin and an organoclay, examining the advantages of a Tunisian clay used for drug delivery applications. The clay mineral studied is a montmorillonite-like smectite (Sm-Na), and the organoclay derivative (HDTMA-Sm) was used as a drug carrier for metformin hydrochloride (MET). In order to assess the MET loading into the clays, these materials were characterized by means of cation exchange capacity assessment, specific surface area measurement, and with the techniques of X-ray diffraction (XRD), differential scanning calorimetry, X-ray fluorescence spectroscopy, and Fourier-transformed infrared spectroscopy. Computational molecular modeling studies showed the surface adsorption process, identifying the clay–drug interactions through hydrogen bonds, and assessing electrostatic interactions for the hybrid MET/Sm-Na and hydrophobic interactions and cation exchange for the hybrid MET/HDTMA-Sm. The results show that the clays (Sm-Na and HDTMA-Sm) are capable of adsorbing MET, reaching a maximum load of 12.42 and 21.97 %, respectively. The adsorption isotherms were fitted by the Freundlich model, indicating heterogeneous adsorption of the studied adsorbate–adsorbent system, and they followed pseudo-second-order kinetics. The calculations of ΔGº indicate the spontaneous and reversible nature of the adsorption. The calculation of ΔH° indicates physical adsorption for the purified clay (Sm-Na) and chemical adsorption for the modified clay (HDTMA-Sm). The release of intercalated MET was studied in media simulating gastric and intestinal fluids, revealing that the purified clay (Sm-Na) and the modified organoclay (HDTMA-Sm) can be used as carriers in controlled drug delivery in future clinical applications. The molecular modeling studies confirmed the experimental phenomena, showing that the main adsorption mechanism is the cation exchange process between proton and MET cations into the interlayer space.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminClayDrug CarriersExcipientsAdsorptionX-Ray DiffractionAluminum SilicatesDrug Delivery SystemsSpectroscopy, Fourier Transform InfraredSilicatesModels, MolecularBentoniteCalorimetry, Differential ScanningDrug Liberation

Stichwörter der Autor:innen

adsorptionclay mineralsdrug releasemetforminmolecular modelingsmectite

Substanzen

MetforminClayDrug CarriersExcipientsAluminum SilicatesSilicatesSmectiteBentonite

Autor:innen und Institutionen

  • Laboratory for the Application of Materials to the Environment, Water and Energy (LR21ES15), Faculty of Sciences of Gafsa, University of Gafsa, Gafsa 2112, Tunisia.
  • Faculty of Sciences of Gafsa, University of Gafsa, Gafsa 2112, Tunisia.
  • National Engineering School of Gafsa, University of Gafsa, Sidi Ahmed Zarroug, Gafsa 2112, Tunisia.
  • Laboratory of Composite Materials and Clay Minerals, National Center for Research in Materials Science, TechnopoleBorjCedria, B.P. 73, Soliman 8027, Tunisia.
  • Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Granada, Campus de Cartuja s/n, 18071 Granada, Spain.
  • Organic Chemistry Laboratory (LR17ES08), Faculty of Sciences of Sfax, University of Sfax, Sfax 3029, Tunisia.

ORCID-Profile: César Viseras, C Ignacio Sainz-Díaz

Förderung

  • Ministerio de Ciencia, Innovación y Universidades
  • Consejería de Economía, Conocimiento, Empresas y Universidad
  • Andalusian Government
  • Spanish Science and Innovation Ministry

Zitieren

APA

Omrani, S., Gamoudi, S., Viseras, C., Moussaoui, Y., & Sainz-Díaz, C. I. (2024). The Use of Organoclays as Excipient for Metformin Delivery: Experimental and Computational Study. Molecules. https://doi.org/10.3390/molecules29194612

Vancouver

Omrani S, Gamoudi S, Viseras C, Moussaoui Y, Sainz-Díaz CI. The Use of Organoclays as Excipient for Metformin Delivery: Experimental and Computational Study. Molecules. 2024. doi:10.3390/molecules29194612

BibTeX
@article{Omrani2024,
  author = {Omrani, Sondes and Gamoudi, Safa and Viseras, César and Moussaoui, Younes and Sainz-Díaz, C Ignacio},
  title = {The Use of Organoclays as Excipient for Metformin Delivery: Experimental and Computational Study},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29194612}
}
Kostenlos starten →